Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.045
-0.055 (-2.62%)
Apr 29, 2026, 11:45 AM EDT - Market open

Microbot Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-13.14-11.44-10.74-13.17-11.31
Upgrade
Depreciation & Amortization
0.050.090.110.10.08
Upgrade
Loss (Gain) From Sale of Assets
--00.01-
Upgrade
Stock-Based Compensation
1.061.351.391.751.39
Upgrade
Other Operating Activities
--02.05-0.01-
Upgrade
Change in Inventory
-0.58----
Upgrade
Change in Accounts Payable
0.50.87-0.68-0.240.32
Upgrade
Change in Other Net Operating Assets
-0.920.3-0.660.010.18
Upgrade
Operating Cash Flow
-13.05-8.83-8.53-11.55-9.35
Upgrade
Capital Expenditures
-0.06-0.03-0.03-0.08-0.07
Upgrade
Investment in Securities
-72.321.562.01-3.753.27
Upgrade
Investing Cash Flow
-72.381.541.97-3.843.2
Upgrade
Issuance of Common Stock
86.247.946.564.32-
Upgrade
Financing Cash Flow
86.247.946.564.32-
Upgrade
Net Cash Flow
0.810.65-0-11.06-6.15
Upgrade
Free Cash Flow
-13.11-8.85-8.57-11.63-9.42
Upgrade
Free Cash Flow Per Share
-0.29-0.57-0.84-1.60-1.33
Upgrade
Levered Free Cash Flow
-8.32-5.87-3.81-6.67-4.94
Upgrade
Unlevered Free Cash Flow
-8.32-5.87-3.81-6.67-4.94
Upgrade
Change in Working Capital
-1.011.18-1.35-0.230.5
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.